Dr. Wade S. Smith, MD

Dr. Smith practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Smith's NPI, 1922064377, was assigned on April 25, 2006. Dr. Smith graduated from University Of Washington School Of Medicine in 1989. Dr. Smith holds California license G71583.

Dr. Smith's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Smith's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Smith to 5 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices. Vendor and product names are available with a free account.

Neurology is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Smith is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Smith's licenses on file in 2 states: California and Florida.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, epilepsy, lower back pain, migraine and chronic headache and stroke among the conditions Dr. Smith treats.

CMS data shows 326 Medicare services from Dr. Smith across 7 procedure codes in 2024, for 299 Medicare patients. Medicare paid $20,611 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 299 Medicare patients who saw Dr. Smith in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 69, with 49% women.

In 2024, Dr. Smith wrote 81 Medicare Part D claims for 17 patients. 88% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $78 in total drug cost. In 2023, CMS named 36 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Smith for performance year 2024, reported as part of a group. Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smith as offering telehealth.

Dmand AI links 375 papers to Dr. Smith, published from 2002 to 2025. 2018 was the busiest year, with 7. The most frequent topics are Stroke, Tomography, X-Ray Computed and Brain Ischemia. Dr. Smith has published most often in Neurocrit Care. Dr. Smith's most frequent co-authors are William P. Dillon, MD, Randall T. Higashida, MD and Max Wintermark, MD.

Dmand AI links Dr. Smith to 10 clinical trials, 4 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Ischemic Stroke, Stroke and Embolism. Stryker Neurovascular sponsors the most, 3.

CMS Open Payments shows 38 general payments to Dr. Smith from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 99% of the total. Stryker Corporation paid the most, $45,775. It also lists 4 research payments totaling $11,900 from 2016 to 2018.

Dmand AI lists 11 awards for Dr. Smith, most recently Most Outstanding Lecture Series of the first year in 2007.

Dr. Smith graduated from University Of Washington School Of Medicine in 1989. Dr. Smith is a member of AAN.

Dr. Smith is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.